Thus one goal of the insulin-dependent diabetes therapy is toprecisely capture the insulin-glucose dynamics of the normal person and design asystem yielding the insulin secretion quantitatively as close to the realmetabolism as possible. This evidence concerns the gene INS and diabetes mellitus.